A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer
CLDN16 presents a promising biomarker that could surpass BRAF-V600E, offering effective clinical utility and revolutionizing PTC molecular typing for precise high-risk identification.
Authors
- Wenli Ma (ORCID: https://orcid.org/0009-0002-4999-3501)
- Quan Li (ORCID: https://orcid.org/0000-0002-0565-9045)
- Minghua Ge (ORCID: https://orcid.org/0000-0001-6726-6418)
- Yiqun Hu (ORCID: https://orcid.org/0009-0002-2334-612X)
- Guowan Zheng (ORCID: https://orcid.org/0000-0001-5731-8325)
- Liehao Jiang
- Yanting Duan (ORCID: https://orcid.org/0000-0003-1572-002X)
- Songjie Shen (ORCID: https://orcid.org/0000-0003-2510-1054)
- Fahuan Song (ORCID: https://orcid.org/0000-0002-4110-5912)
- Yao Chen (ORCID: https://orcid.org/0000-0001-7231-9860)
- Yawen Guo (ORCID: https://orcid.org/0000-0002-9575-4192)
- Pu Cheng (ORCID: https://orcid.org/0000-0002-0226-3467)
- Yefeng Cai (ORCID: https://orcid.org/0009-0009-3177-271X)
- Lei Zhu (ORCID: https://orcid.org/0000-0002-2993-7142)
- Xiujun Cai
Institutions
- Zhejiang Chinese Medical University (CN)
- Bengbu Medical College (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Sir Run Run Shaw Hospital (CN)
- Lishui Central Hospital (CN)
- Zhejiang Provincial People's Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Hangzhou Medical College (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1093/ejendo/lvaf003
- Citations
- 2
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- National Natural Science Foundation of China